Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
View Top Employees from Vividion Therapeutics, Inc.| Website | http://www.vividion.com |
| Revenue | $34.4 million |
| Funding | $290.7 million |
| Employees | 210 (189 on RocketReach) |
| Founded | 2017 |
| Address | 5820 Nancy Ridge Dr, San Diego, California 92121, US |
| Phone | (858) 345-4690 |
| Technologies |
JavaScript,
HTML,
Twitter
+29 more
(view full list)
|
| Category | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Science and Engineering, Health Care, Therapeutics |
| Web Rank | 7 Million |
| Keywords | vividion therapeutics, vividion, vividion diego, san diego oncology companies |
| Competitors | Atreca, Inc., Bolt Biotherapeutics, Inc., IDEAYA Biosciences, ORIC Pharmaceuticals Inc., Zentalis Pharmaceuticals |
| SIC | 87, 873 |
| NAICS | 54, 541, 5413, 54138 |
Looking for a particular Vividion Therapeutics, Inc. employee's phone or email?
Vividion Therapeutics, Inc. Questions
The Vividion Therapeutics, Inc. annual revenue was $34.4 million in 2023.
Jeff Hatfield is the CEO of Vividion Therapeutics, Inc..
189 people are employed at Vividion Therapeutics, Inc..
Vividion Therapeutics, Inc. is based in San Diego, California.
The NAICS codes for Vividion Therapeutics, Inc. are [54, 541, 5413, 54138].
The SIC codes for Vividion Therapeutics, Inc. are [87, 873].
Top Vividion Therapeutics, Inc. Employees
-
22
-
12
-
33
-
12
-
15
-
35+
-
35+
Related Companies
